Llerena BLI, Miranda AAP, Herrera MM, Garza D, Ruvalcaba LE, Domínguez C, Tenorio TJA, Villegas CF Moreno FG

Language: Spanish
References: 5
Page: 28-30
PDF size: 235.80 Kb.

ABSTRACT

The malignant phyllodes tumor is one of the fibroepithelial tumors that represents 1%, symptoms due to excessive stromal growth, increased mitosis, with local recurrences of 23 to 30% within 2 to 3 years, the treatment is excision surgical with margins greater than 1 cm to avoid recurrences, quickly of radiotherapy, without evidence of chemotherapy. We present the case of an adult woman, with a malignant phyllodes tumor, with multiple recurrences, who has an aggressive behavior, with multimodal treatment, treated with surgery, radiotherapy and chemotherapy.

REFERENCES

1. Li J, Tsang JY, Chen C et al. Predicting outcome in mammary phyllodes tumors: relevance of clinicopathological features. Ann Surg Oncol. 2019; 26 (9): 2747-2758. doi: 10.1245/s10434-019-07445-1.

2. Limaiem F, Waheed A. Cáncer, phyllodes tumor de la mama (cistosarcoma) [Actualizado en 2019 el 4 de junio]. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK541138/

3. Chao X, Chen K, Zeng J et al. Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer. 2019; 19 (1): 372. doi: 10.1186/s12885-019-5585-5.

4. Tan BY, Acs G, Apple SK et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016; 68 (1): 5-21. doi: 10.1111/his.12876.

5. Jiménez-López J, Márquez-Acosta G, Olaya Guzmán EJ, Gómez-Pue D, Arteaga Gómez AC. Tumor phyllodes. Perinatol Reprod Hum. 2013; 27 (2): 106-112.